227 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
by the U.S. Department of Justice and the U.S. Attorney's Office for the District of Massachusetts), the ultimate outcome of any such proceedings
8-K
REGN
Regeneron Pharmaceuticals, Inc.
31 Jan 24
Departure of Directors or Certain Officers
4:17pm
of increasing responsibility in the Company’s accounting department. Prior to joining the Company in 2011, he was a Senior Manager
8-K
EX-99.1
w24xgui7hnsx3t3m
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
SC TO-T
EX-99
swqedtf4
25 Aug 23
Third party tender offer statement
7:46am
SC TO-C
am1vu
9 Aug 23
Information about tender offer
4:15pm
SC TO-C
EX-99.1
f6w7e
9 Aug 23
Information about tender offer
4:15pm
SC TO-C
EX-99.2
04qrj2
9 Aug 23
Information about tender offer
4:15pm
PX14A6G
p6ci2nhojjfek bf
18 May 23
Letter to shareholders
4:46pm
8-K
EX-10.1
9b563c 5z9kp6pep
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
t8cvf m4f
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
45ulyf7zl 8clwmmz1o
20 Dec 22
Entry into a Material Definitive Agreement
4:01pm